About Metabolomics

Shown here is a trace from a non-targeted metabolomics run, leading to typical coverage of 500 – 2,000 annotated metabolites.

While a limited number of academic and industrial researchers and clinicians have demonstrated the potential of metabolomics, significant time and cost constraints have limited the broader application of this technology.

 

For the first time, General Metabolics brings scale to metabolomics to allow these powerful studies to become a regular part of the R&D workflow to identify markers of disease, to assess target engagement, to mechanistically link targets to broader cellular physiology or to evaluate patient response to treatment.